List of Tables
Table 1. Immuno Oncology Assays Market Trends
Table 2. Immuno Oncology Assays Market Drivers & Opportunity
Table 3. Immuno Oncology Assays Market Challenges
Table 4. Immuno Oncology Assays Market Restraints
Table 5. Global Immuno Oncology Assays Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Immuno Oncology Assays Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Immuno Oncology Assays Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Immuno Oncology Assays Product Type
Table 9. Key Companies Time to Begin Mass Production of Immuno Oncology Assays
Table 10. Global Immuno Oncology Assays Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Immuno Oncology Assays Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Immuno Oncology Assays Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Immuno Oncology Assays Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Immuno Oncology Assays Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Immuno Oncology Assays Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Immuno Oncology Assays Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Immuno Oncology Assays Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Immuno Oncology Assays Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Immuno Oncology Assays Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Immuno Oncology Assays Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Immuno Oncology Assays Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Immuno Oncology Assays Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Immuno Oncology Assays Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Immuno Oncology Assays Sales Value by Region (2019-2024) & (%)
Table 27. Global Immuno Oncology Assays Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Immuno Oncology Assays Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Immuno Oncology Assays Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Immuno Oncology Assays Sales Value, (2025-2030) & (US$ Million)
Table 31. Thermo Fischer Scientific Basic Information List
Table 32. Thermo Fischer Scientific Description and Business Overview
Table 33. Thermo Fischer Scientific Immuno Oncology Assays Products, Services and Solutions
Table 34. Revenue (US$ Million) in Immuno Oncology Assays Business of Thermo Fischer Scientific (2019-2024)
Table 35. Thermo Fischer Scientific Recent Developments
Table 36. Roche Diagnostics Basic Information List
Table 37. Roche Diagnostics Description and Business Overview
Table 38. Roche Diagnostics Immuno Oncology Assays Products, Services and Solutions
Table 39. Revenue (US$ Million) in Immuno Oncology Assays Business of Roche Diagnostics (2019-2024)
Table 40. Roche Diagnostics Recent Developments
Table 41. Agilent Technologies Basic Information List
Table 42. Agilent Technologies Description and Business Overview
Table 43. Agilent Technologies Immuno Oncology Assays Products, Services and Solutions
Table 44. Revenue (US$ Million) in Immuno Oncology Assays Business of Agilent Technologies (2019-2024)
Table 45. Agilent Technologies Recent Developments
Table 46. Illumina Basic Information List
Table 47. Illumina Description and Business Overview
Table 48. Illumina Immuno Oncology Assays Products, Services and Solutions
Table 49. Revenue (US$ Million) in Immuno Oncology Assays Business of Illumina (2019-2024)
Table 50. Illumina Recent Developments
Table 51. Key Raw Materials Lists
Table 52. Raw Materials Key Suppliers Lists
Table 53. Immuno Oncology Assays Downstream Customers
Table 54. Immuno Oncology Assays Distributors List
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Immuno Oncology Assays Product Picture
Figure 2. Global Immuno Oncology Assays Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
Figure 4. Immuno Oncology Assays Report Years Considered
Figure 5. Global Immuno Oncology Assays Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Immuno Oncology Assays Revenue in 2023
Figure 7. Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immunoassay Picture
Figure 9. Flow Cytometry Picture
Figure 10. PCR Picture
Figure 11. Next Generation Sequencing Picture
Figure 12. Global Immuno Oncology Assays Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Immuno Oncology Assays Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Research
Figure 15. Product Picture of Clinical Diagnostics
Figure 16. Global Immuno Oncology Assays Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Immuno Oncology Assays Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Immuno Oncology Assays Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Immuno Oncology Assays Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Immuno Oncology Assays Sales Value (%), (2019-2030)
Figure 29. United States Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 35. China Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 37. China Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 47. India Immuno Oncology Assays Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Immuno Oncology Assays Sales Value by Type (%), 2023 VS 2030
Figure 49. India Immuno Oncology Assays Sales Value by Application (%), 2023 VS 2030
Figure 50. Immuno Oncology Assays Industrial Chain
Figure 51. Immuno Oncology Assays Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation